Summary
Rat isolated tracheae were labelled by incubation with [3H]choline to measure the tritium efflux elicited by electrical stimulation of the extrinsic parasympathetic nerves in vitro. Stimulated tritium efflux reflects the neuronal release of newly synthesized acetylcholine; the effects of potassium channel openers on the stimulated tritium efflux were investigated. In tracheae opened longitudinally neither cromakalim nor its 3S,4R-enantiomer, BRL 38227, reduced the stimulated tritium efflux, whereas in intact tube-preparations cromakalim (0.01–1 μmol/l) mediated a concentration-dependent inhibition. The inhibitory effect of 1 μmol/l cromakalim was prevented by 0.1 μmol/l glibenclamide. Likewise, BRL 38227 (0.01 and 0.1 μmol/l) inhibited the stimulated tritium efflux, but the inhibitory effect vanished at high concentrations (1 and 10 μmol/l). The 3R,4S-enantiomer of cromakalim, BRL 38226 (0.1, 1 and 10 μmol/l), on its own did not significantly inhibit the stimulated tritium efflux, but a combination of both enantiomers (0.5 or 1 μmol/l of each) produced an inhibition similar to that caused by 1 μmol/l cromakalim. In epithelium-denuded tube-preparations neither cromakalim nor BRL 38227 reduced the stimulated tritium efflux. The mucosal/submucosal microenvironment is better preserved in intact tube-preparations than in longitudinally-opened tracheae which are cut along their whole length so that the luminal surface is exposed directly to the surrounding medium. The present experiments show an neuronal inhibitory effect of cromakalim which is mediated by an epithelium-dependent mechanism.
Similar content being viewed by others
References
Arch JRS, Buckle DR, Bumstead J, Clarke GD, Taylor JF, Taylor SG (1988) Evaluation of the potassium channel activator cromakalim (BRL 34915) as a bronchodilator in the guinea-pig: comparison with nifedipine. Br J Pharmacol 95:763–770
Berry JL, Eliott KRF, Foster RW, Green KA, Murray MA, Small RC (1991) Mechanical, biochemical and electrophysiological studies of RP 49356 and cromakalim in guinea-pig and bovine trachealis muscle. Pulm Pharmacol 4:91–98
Black JL, Armour CL, Johnson PRA, Alouan LA, Barnes PJ (1990) The action of a potassium channel activator, BRL 38227 (lemakalim), on human airway smooth muscle. Am Rev Respir Dis 142:1384–1389
Bolton TB, Lang RJ, Takewaki T (1984) Mechanisms of action of noradrenaline and carbachol on smooth muscle of guinea-pig anterior mesenteric artery. J Physiol (Lond) 351:549–572
Bray K, Quast U (1991) Differences in the K+-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery. Br J Pharmacol 102:585–594
Burka JF, Berry JL, Foster RW, Small RC, Watt AJ (1991) Effects of cromakalim on neurally-mediated responses of guinea-pig tracheal smooth muscle. Br J Pharmacol 104:263–269
Chen G, Suzuki H, Weston AH (1988) Acetylcholine releases endothelium derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 95:1165–1174
Eckmann DM, Frankovich JD, Keef KD (1992) Comparison of the actions of acetylcholine and BRL 38227 in the guinea-pig coronary artery. Br J Pharmacol 106:9–16
Feletou M, Vanhoutte PM (1988) Endothelium-dependent hyperpolarization of canine coronary artery smooth muscle. Br J Pharmacol 93:515–524
Goldie RG, Fernandes LB, Farmer SG, Hay DWP (1990) Airway epithelium-derived inhibitory factor. Trends Pharmacol Sci 11:67–70
Hall AK, Maclagan J (1988) Effect of cromakalim on cholinergic neurotransmission in the guinea-pig trachea. Br J Pharmacol 95:792P
Hamilton TC, Weir SW, Weston AH (1986) Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 88:103–111
Hamilton TC, Weston AH (1989) Cromakalim, nicorandil and pinacidil: Novel drugs which open potassium channels in smooth muscle. Gen Pharmacol 20:1–9
Hof RP, Quast U, Cook NS, Blarer S (1988) Mechanism of action and systemic and regional hemodynamics of the potassium channel activator BRL34915 and its enantiomers. Circ Res 62:679–686
Hollingsworth M, Amedee T, Edwards D, Mironneau J, Savineau JP, Small RC, Weston AH (1987) The relaxant action of BRL 34915 in rat uterus. Br J Pharmacol 91:803–813
Ichinose M, Barnes PJ (1990) A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea-pig airways. J Pharmacol Exp Ther 252:1207–1212
Klaus E, Englert HC, Linz W, Bartsch C, Schölkens BA (1992) Effects of the potassium channel openers HOE 234 and lemakalim in rat aorta. Naunyn Schmiedeberg's Arch Pharmacol 345 [Suppl]:R71
Kuo HP, Rohde JAL, Barnes PJ, Rogers DF (1992) K+ channel activator inhibition of neurogenic goblet cell secretion in guniea-pig trachea. Eur J Pharmacol 215:297–299
Lückhoff A, Busse R (1990) Activators of potassium channels enhance calcium influx into endothelial cells as a consequence of potassium currents. Naunyn-Schmiedeberg's Arch Pharmacol 342:94–99
McCaig DJ, De Jonckheere B (1989) Effect of cromakalim on bronchoconstriction evoked by cholinergic nerve stimulation in guineapig isolated trachea. Br J Pharmacol 98:662–668
Quast U, Baumlin Y (1988) Comparison of the effluxes of 42K+ and 86Rb+ elicited by cromakalim (BRL 34915) in tonic and phasic vascular tissue. Naunyn-Schmiedeberg's Arch Pharmacol 338:319–326
Shetty SS, Weiss GB (1987) Dissociation of the actions of BRL 34915 in the rat portal vein. Eur J Pharmacol 141:485–488
Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864–989
Taylor SG, Weston AH (1988) Endothelium derived hyperpolarizing factor: an endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci 9:272–274
Wallenstein S, Zucker CL, Fleiss JI (1980) Some statistical methods useful in circulation research. Circ Res 47:1–9
Wessler I (1992) Acetylcholine at motor nerves: storage, release and presynaptic modulation by autoreceptors and adrenoceptors. Int Rev Neurobiol 34:283–384
Wessler I, Pohan D (1992) Neuro-epithelial interactions in the isolated rat trachea: effects of potassium channel openers and agonists at β-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 345[Suppl]: R99
Wessler I, Hellwig D, Racke K (1990) Epithelium-derived inhibition of [3H]acetylcholine release from the isolated guinea-pig trachea. Naunyn-Schmiedeberg's Arch Pharmacol 342:387–393
Wessler I, Klein A, Pohan D, Maclagan J, Racké K (1991) Release of [3H]acetylcholine from the isolated rat or guinea-pig trachea evoked by preganglionic nerve stimulation; a comparison with transmural stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 344: 403–411
Wessler I, Pohan D, Maclagan J, Racke K (1992) Chromakalim inhibits [3H]acetylcholine release from parasympathetic nerves of the isolated rat trachea via an epithelium-dependent mechanism. Br J Pharmacol 105[Suppl]:69P
Author information
Authors and Affiliations
Additional information
Correspondence to I. Wessler at the above address
Rights and permissions
About this article
Cite this article
Wessler, I., Hölz, C., Maclagan, J. et al. Cromakalim inhibits electrically-evoked [3H] acetylcholine release from a tube-preparation of the rat isolated trachea by an epithelium-dependent mechanism. Naunyn-Schmiedeberg's Arch Pharmacol 348, 14–20 (1993). https://doi.org/10.1007/BF00168531
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168531